Submitted by Anonymous (not verified) on 7 July 2026 - 14:46
Opinion/decision on a Paediatric investigation plan (PIP): Yorvipath, palopegteriparatide, decision type: PM: decision on the application for modification of an agreed PIP, therapeutic area: Endocrine disorders, PIP number: EMA/PE/0000241327
Source: